OP
COLL icon

ORG Partners’s Collegium Pharmaceutical COLL Stock Holding History

ORG Partners’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.39K Buy
+30
New +$1.25K ﹤0.01% 1495

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ORG Partners's COLL Position: Q4 2025 in Review

ORG Partners opened a new position in Collegium Pharmaceutical (COLL) in Q4 2025: 30 shares worth $1.39K. The stake represents ﹤0.01% of the portfolio and ranks #1495 among its holdings.

278 funds tracked by Wall St. Rank hold COLL as of Q4 2025.

  • ORG Partners held 30 shares of Collegium Pharmaceutical worth $1.39K as of Q4 2025.
  • Collegium Pharmaceutical was a new ORG Partners position in Q4 2025.
  • Collegium Pharmaceutical made up ﹤0.01% of ORG Partners's portfolio in Q4 2025, its #1495 holding.
  • 278 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.